Clazosentan reduces risk of blood vessel spasm in patients with brain aneurysm
An experimental drug, clazosentan, reduced the risk of blood vessel spasm in patients with a brain aneurysm, according to research presented at the American Stroke Association's International Stroke Conference 2012.
Two new drugs could slash stroke risk and blood clots for those with atrial fibrillation, a heart rhythm problem, a study suggests.